ABB's automation delivers first-of-its-kind disability home
ABB Group, a global leader in smart home automation, has provided groundbreaking technology to a home for people with disabilities in Australia.
ABB's KNX solution is supporting first-of-its-kind accomodation Casa Capace, enabling residents to live independently thanks to its automation technology.
Australia's National Disability Insurance Scheme (NDIS) plans to provide housing for 28,000 people with disabilities. To help realise this, the Australian government invited the commercial property sector to design suitable homes, which have historically often felt more like hospitals than places to live.
Property investors DPN decided on "Casa Capace" as the name for the project, which roughly translates as "capable home". They chose ABB i-bus® KNX as the solution to deliver the dwellings' automation technology.
There are currently two dwellings, each with six bedrooms. The homes are fully compliant with NDIS design requirements, featuring oversized doors and corridors and open-plan spaces to allow for mobility devices. They also have customisable fittings such as supports in ceilings to accommodate hoists, and adjustable kitchen benches, sinks and basins for wheelchair usage.
Electrical doors, lighting, blinds, heating and cooling in each room are all controlled by ABB i-bus® KNX automation. It can adjust the height of benches, raise blinds and switch lights off in the morning, and turn on the TV and dim lights in the evening.
These are controllable via an app, voice activated through Siri, or on the resident’s device. "Casa Capace residents in wheelchairs can navigate the home with ease thanks to a voice control function allowing them to open and close doors. Height adjustable benchtops in the kitchen and laundry are accessible from a standing or seated position, enabling residents to to do their chores independently" Schiemann says.
There is even an accessible garden that is 600mm high, making gardening from a wheelchair possible.
The project has been a great success. DPN Group Managing Director Sam Khalil, commented: “We wanted to create a designer home that anybody would walk into and say, ‘I would love to have this as my home’, and not to be able to tell that it’s been built as a disabled-care home in any way.”
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”